EXCLUSIVE: Relypsa Being Evaluated By 3-4 Potential Acquirers; Sanofi Seen As 'Natural Buyer'

By: via Benzinga
Relypsa Inc (NASDAQ: RLYP) shares are up more than 16 percent on Friday afternoon after unconfirmed reports that Merck & Co., ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.